JPRN-UMIN000010167已完成2 期
A Phase II Study of SI-613 in Patients with Knee Osteoarthritis - A Phase II Study of SI-613 in Patients with Knee Osteoarthritis
SEIKAGAKU CORPORATIO0 个研究点目标入组 120 人开始时间: 2013年3月6日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •-Patients with secondary OA resulting from trauma or other diseases -Patients with risk of infection in the area of the injection site due to skin disease or infection
研究者
相似试验
已完成
不适用
A Phase II Study of SI-613 in Patients with Knee Osteoarthritis (repeat-dose study)Knee OsteoarthritisJPRN-UMIN000015858SEIKAGAKU CORPORATIO160
已完成
3 期
A Phase III Study of SI-613 in Patients with Knee Osteoarthritis (confirmatory study)Knee osteoarthritisJPRN-jRCT2080223482SEIKAGAKU CORPORATIO440
Unknown
2 期
Study of SI000413 in Knee Osteoarthritis PatientsOsteoarthritis, KneeNCT01525758Dong-A Pharmaceutical Co., Ltd.152
已完成
2 期
Intra-articular Injection of Allogenic Lyophilized Growth Factors in Primary Knee OsteoarthritisOsteo Arthritis KneeNCT04331327Rasmia Elgohary31
已完成
不适用
Health outcomes following SYNVISC-ONE in Knee OsteoarthritisACTRN12616001504404The University of Queensland130